Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Guiducci

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Rheumatology (Oxford, England)|July 7, 2005
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytesA Del Rosso, M Cinelli, S Guiducci, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosisM Manetti, V Liakouli, C Fatini, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvementA Del Rosso, O Distler, A F Milia, et al.
Arthritis and Rheumatism|November 17, 2001
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesisO Distler, T Pap, O Kowal-Bielecka, et al.
Clinical Rheumatology|February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experienceS Bellando-Randone, C Bruni, G Lepri, et al.
Annals of the Rheumatic Diseases|December 8, 2007
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control studyB Rozman, S Cucnik, S Sodin-Semrl, et al.
Annals of the Rheumatic Diseases|July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cellsJ H W Distler, Y Allanore, J Avouac, et al.
Rheumatology (Oxford, England)|February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosisF Bartoli, C Angotti, C Fatini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implicationsE Romano, M Manetti, F Peruzzi, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Rheumatology (Oxford, England)|July 7, 2005
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytesA Del Rosso, M Cinelli, S Guiducci, et al.
Arthritis Research & Therapy|November 10, 2005
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritisS Guiducci, A Del Rosso, M Cinelli, et al.
Annals of the Rheumatic Diseases|October 22, 2008
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosisM Manetti, V Liakouli, C Fatini, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvementA Del Rosso, O Distler, A F Milia, et al.
Arthritis and Rheumatism|November 17, 2001
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesisO Distler, T Pap, O Kowal-Bielecka, et al.
Clinical Rheumatology|February 23, 2018
The safety of iloprost in systemic sclerosis in a real-life experienceS Bellando-Randone, C Bruni, G Lepri, et al.
Annals of the Rheumatic Diseases|December 8, 2007
Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control studyB Rozman, S Cucnik, S Sodin-Semrl, et al.
Annals of the Rheumatic Diseases|July 26, 2008
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cellsJ H W Distler, Y Allanore, J Avouac, et al.
Rheumatology (Oxford, England)|February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosisF Bartoli, C Angotti, C Fatini, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 7, 2013
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implicationsE Romano, M Manetti, F Peruzzi, et al.
Pageof 6